Robert Hombach

Director/Board Member at BIOMARIN PHARMACEUTICAL INC.

Net worth: 3 M $ as of 30/12/2025

60 year

100 connections

Distribution Services

Health Technology

Retail Trade

Profile

Robert J.
Hombach currently serves as Independent Director at BioMarin Pharmaceutical, Inc. since 2017, Director at EDGe Surgical, Inc., Independent Director at Embecta Corp.
since 2022, Independent Director at Henry Schein, Inc. starting 2025, Director at Seaport Therapeutics, Inc. starting 2025, and Industry Advisor at Agent Capital LLC.
Former roles include Independent Director at CarMax, Inc. from 2018 to 2022, Director at Naurex, Inc., Director at Loyola University Health System, President & Director at Baxter International Foundation, Independent Director at Aptinyx, Inc. from 2018 to 2023, Director at Surgical Innovation Associates, Inc. from 2017 to 2022, Chief Financial Officer & Vice President at Baxter International, Inc. from 2011 to 2015, and Executive VP, Chief Operations & Financial Officer at Baxalta, Inc. from 2015 to 2016.
Education includes an undergraduate degree from The University of Colorado in 1988 and an MBA from Kellogg School of Management in 1997.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOMARIN PHARMACEUTICAL INC. 0.02%	19/05/2025	41,870 ( 0.02% )	2 M $	30/12/2025
EMBECTA CORPORATION 0.05%	30/11/2025	26,863 ( 0.05% )	319 132 $	30/12/2025
HENRY SCHEIN, INC. 0%	03/03/2025	2,844 ( 0% )	214 950 $	30/12/2025

Latest news about Robert Hombach

29/01/25	Henry Schein Confirms KKR Investment, Board Updates, Sets Q4, 2025 Outlook	MT
29/01/25	Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal	DJ
29/01/25	Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance	BU
29/01/25	Henry Schein, Inc. Announces Board Changes	CI
23/04/24	BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K	PU

Robert Hombach active positions

Companies	Position	Start
BIOMARIN PHARMACEUTICAL INC.	Director/Board Member	28/09/2017
EMBECTA CORP.	Director/Board Member	19/03/2022
HENRY SCHEIN, INC.	Director/Board Member	28/01/2025
EDGe Surgical, Inc. EDGe Surgical, Inc. Manufactures electronic depth gauge devices for orthopedic surgery	Director/Board Member	-
Agent Capital LLC Agent Capital LLC Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments.	Consultant / Advisor	-

All active positions of Robert Hombach

Former positions of Robert Hombach

Companies	Position	End
APTINYX	Director/Board Member	29/06/2023
CARMAX, INC.	Director/Board Member	27/06/2022
Surgical Innovation Associates, Inc. Surgical Innovation Associates, Inc. Manufactures and sells mono filament mesh for plastic and reconstructive surgery	Director/Board Member	31/12/2021
BAXALTA INC	Director of Finance/CFO	31/05/2016
░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░

See the detail of Robert Hombach's experience

Training of Robert Hombach

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Hombach's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Baxter International, Inc. Baxter International, Inc. Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services
Henry Schein, Inc. Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services	Distribution Services
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
CarMax, Inc. CarMax, Inc. Specialty StoresRetail Trade Operates as a holding company whose subsidiaries retails and finance used motor vehicles	Retail Trade
Naurex, Inc. Naurex, Inc. Operates as a clinical-stage company, which develops novel therapies
Baxalta, Inc. Baxalta, Inc. Engages in research, development and manufacture of therapies and biopharmaceutical products
The University of Colorado The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Loyola University Health System Loyola University Health System Hospital/Nursing ManagementHealth Services Provides health care services	Health Services
Baxter International Foundation
Kellogg School of Management Kellogg School of Management Functions as a College/University
Aptinyx, Inc. Aptinyx, Inc. Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system
Surgical Innovation Associates, Inc. Surgical Innovation Associates, Inc. Manufactures and sells mono filament mesh for plastic and reconstructive surgery
EDGe Surgical, Inc. EDGe Surgical, Inc. Manufactures electronic depth gauge devices for orthopedic surgery
Agent Capital LLC Agent Capital LLC Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments.
Embecta Corp. Embecta Corp. Manufactures and distributes medical devices for the treatment of diabetes